Sherry Group’s Annovis Bio ANVS Stock Holding History

Sherry Group’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$72.7K	Hold	57,270	–	–	0.07%	51
2026 Q2	$107K	Hold	57,270	–	–	0.1%	51
2026 Q1	$128K	Buy	57,270 +30,000	+110%	+$82.3K	0.14%	40
2025 Q4	$94.4K	Buy	+27,270	New	+$82K	0.1%	43

Other funds holding ANVS

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Sherry Group's ANVS Position: Q3 2026 in Review

Sherry Group held its Annovis Bio (ANVS) position steady in Q3 2026 at 57,270 shares worth $72.7K. The position accounts for 0.07% of the portfolio, ranked #51.

Sherry Group first reported a position in ANVS in Q4 2025 and has held it in 4 quarters since. The position peaked at $128K in Q1 2026. 2 funds tracked by Wall St. Rank hold ANVS as of Q3 2026.

Sherry Group held 57,270 shares of Annovis Bio worth $72.7K as of Q3 2026.
Sherry Group left its Annovis Bio share count unchanged in Q3 2026.
Annovis Bio made up 0.07% of Sherry Group's portfolio in Q3 2026, its #51 holding.
Sherry Group first reported a position in Annovis Bio in Q4 2025 and has held it in 4 quarters since.
Sherry Group's Annovis Bio position peaked at $128K in Q1 2026.
2 funds tracked by Wall St. Rank held Annovis Bio as of Q3 2026.

Based on Sherry Group's 13F filing for Q3 2026, filed 9 Oct 2026.